Antibiotic prophylaxis for women undergoing caesarean section and infant health

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 123, Issue 6, 2016, Pages 875-876

  Bailey, S R ^a   Field, N ^b   Townsend, C L ^a   Rodger, A J ^b   Brocklehurst, P ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADVERSE OUTCOME; ANTIBIOTIC PROPHYLAXIS; CESAREAN SECTION; CHILD HEALTH; DRUG EFFECT; ENDOMETRITIS; HUMAN; INCISION; INFECTION PREVENTION; INTESTINE FLORA; MATERNAL MORBIDITY; MATERNAL MORTALITY; MICROBIAL COLONIZATION; NOTE; OUTCOME ASSESSMENT; POSTOPERATIVE INFECTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PUERPERAL INFECTION; RISK FACTOR; RISK REDUCTION; URINARY TRACT INFECTION; WOUND INFECTION; ADVERSE EFFECTS; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; LITERATURE; NEWBORN; PRACTICE GUIDELINE; PREGNANCY; PRENATAL EXPOSURE; TIME FACTOR;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CESAREAN SECTION; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INFANT, NEWBORN; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REVIEW LITERATURE AS TOPIC; TIME FACTORS;

EID: 84964319758     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.13701     Document Type: Note

References (11)

1. NICE. Caesarean section: full guideline. NICE clinical guideline 132. London: NICE, 2011.
2. Mackeen AD, Packard RE, Ota E, Berghella V, Baxter JK,. Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery. Cochrane Database Syst Rev 2014: CD009516.
3. Statistical bulletin: Births in England and Wales by Characteristics of Birth 2, 2013 release. London: Office for National Statistics, 2014.
4. NICE. Caesarean section: full guideline. NICE clinical guideline 13. London: NICE, 2004.
5. Lawley TD, Walker AW,. Intestinal colonization resistance. Immunology 2013; 138: 1-11.
6. Adkins B, Leclerc C, Marshall-Clarke S,. Neonatal adaptive immunity comes of age. Nature Rev Immunol 2004; 4: 553-64.
7. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, et al., Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 2010; 107: 11971-5.
8. Penders J, Thijs C, van den Brandt PA, Kummeling I, Snijders B, Stelma F, et al., Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 2007; 56: 661-7.
9. Honda K, Littman DR,. The microbiome in infectious disease and inflammation. Ann Rev Immunol 2012; 30: 759-95.
10. Murgas Torrazza R, Neu J,. The developing intestinal microbiome and its relationship to health and disease in the neonate. J Perinatol 2011; 31 (Suppl 1): S29-34.
11. Knight MKS, Brocklehurst P, Neilson J, Shakespeare J, Kurinczuk JJ, (eds) on behalf of MBRRACEUK. Saving Lives, Improving Mothers' Care-Lessons learned to inform future maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009-12. Oxford: National Perinatal Epidemiology Unit, University of Oxford. 2014.